Actively hiring
Drug Discovery
Health Care
Psychiatric Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$193.9M
5 rounds on record
Latest round
$50M
Venture round · Oct 2025 · 11 mo ago
The money's age
Fresh money
11 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 21, 2025
Raised a round Venture round $50M · SEC Form D
Nov 20, 2023
Raised a round Venture round $45M · SEC Form D
Apr 6, 2022
Raised a round Venture round $59.3M · SEC Form D
May 3, 2021
Raised a round Venture round $31.9M · SEC Form D
Sep 13, 2019
Raised a round Venture round $7.7M · SEC Form D
2019
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2025 | $50M | — | SEC Form D |
| Venture round | Nov 2023 | $45M | — | SEC Form D |
| Venture round | Apr 2022 | $59.3M | — | SEC Form D |
| Venture round | May 2021 | $31.9M | — | SEC Form D |
| Venture round | Sep 2019 | $7.7M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Alto Neuroscience, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Adam SavitzExecutive OfficerSEC Form D
Amit EtkinExecutive Officer, DirectorSEC Form D
Nicholas SmithExecutive OfficerSEC Form D
Michael HanleyExecutive OfficerSEC Form D
Similar startupsby what they do, their industry and backers

Precision biomarkers that quantify functional brain change. Supporting drug development and brain health programs.

Ngmbio develops life-changing medicines rooted in powerful biology, including NGM120 for hyperemesis gravidarum and cancer cachexia.

Drug discovery at the resolution of biology. Using the power of the transcriptome to discover revolutionary medicines.

Build better molecules with frontier AI models. With AI, we help every scientist reshape biology.

Our Mission, Technology, and Approach April 7, 2025 At Nudge, our mission is to develop the best technology for interfacing with the brain…

CoSyne Therapeutics is a vertically integrated AI drug discovery company aiming to bring speed to precision medicine through polymathic AI…
News
Alto Neuroscience Announces Pricing of $100.0 Million Underwritten Registered Direct Offering of Common Stock
Read more
Report
Alto Neuroscience Announces Completion of Enrollment in Phase 2 Proof-of-Concept Study of ALTO-101 in Cognitive Impairment Associated with Schizophrenia
Alto Neuroscience, Inc., a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the completion of patient enrollment in its Phase 2 proof-of-concept clinical trial
Read more
Report
Is Alto Neuroscience, Inc. (ANRO) Outperforming Other Medical Stocks This Year?
Here is how Alto Neuroscience, Inc. (ANRO) and Editas Medicine (EDIT) have performed compared to their sector so far this year.
Read more
Report
Pro access
Upgrade to see all 11 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People

Adam Savitz
Executive Officer

Amit Etkin
Executive Officer, Director

Nicholas Smith
Executive Officer

Michael Hanley
Executive Officer

Michael Liang
Director

Christopher Cox
Director

Po Yu Jeff Chen
Director

Andrew Dreyfus
Director

Aaron Weaver
Director

Chris Dimitropoulos
Director

Gwill York
Director

Husseini Manji
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Los Altos
United States
HQ
Mountain View
United States
Regional office
Interested in joining the Alto team?Visit our Careers page to see our available opportunities.
650 Castro Street, Suite 450, Mountain View, CA 94041
Financials
Total raised
$193.9M
Latest round
Venture - Series Unknown
Funding rounds
5
